HIGH POINT, N.C., Aug. 26, 2014 – High Point University has appointed two of the nation’s leading businessmen to its National Board of Advisors: Tim Belk, chairman and CEO of Belk Stores, and David King, CEO of LabCorp, one of the world’s largest clinical laboratories. Both companies are headquartered in North Carolina, with Belk’s headquarters in Charlotte and LabCorp’s in Burlington.
The board is comprised of leaders in education, Fortune 500 CEOs, and distinguished visionaries who are positively impacting the United States and the world in significant ways. It includes Gen. Colin Powell, former secretary of state, chairman of the Joint Chiefs of Staff and national security advisor; Steve Wozniak, Apple co-founder; Dr. James Moeser, chancellor emeritus at the University of North Carolina at Chapel Hill; Ron Wanek, founder and chairman of Ashley Furniture; Kelly King, chairman and CEO of BB&T; Marty Flanagan, president and CEO of Invesco Ltd. Invesco; Bonnie McElveen-Hunter, CEO and owner of Pace Communications, chairwoman of the American Red Cross and former U.S. Ambassador to Finland; Kurt L. Darrow, president and CEO of La-Z-Boy; and Rich Handler, CEO and director of Leucadia and CEO and chairman of the board for Jeffries Group, a global investment banking firm headquartered in New York.
“These two men head nationally recognized companies that are based in our state,” says Dr. Nido Qubein, HPU president. “They provide valuable insight to our board and help our students reach new heights as we prepare them for careers of tomorrow.”
Tim Belk leads the nation’s largest privately owned mainline department store company with more than 300 fashion department stores in 16 contiguous Southern states and sales totaling $3.5 billion in its past fiscal year.
David King heads one of the largest clinical lab providers in the world. LabCorp, based out of Burlington, operates a sophisticated laboratory network with more than 34,000 employees and 220 thousand clients, including physician offices, hospitals, managed care organizations and biotechnology and pharmaceutical companies.